Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

Intact Vascular, TOBA clinical study, one-year results, Tack Endovascular System, Journal of Vascular Surgery
News | Peripheral Artery Disease (PAD) | August 24, 2016
August 24, 2016 — Intact Vascular Inc. announced that the one-year results from its Tack Optimized Balloon Angioplasty...
Absorb, bioresorbable stent, BVS, on OCT

An optical coherence tomography (OCT) image of an Absorb bioresorbable stent. The stent struts are clear, allowing light to pass through, and in some cases magnifying the light that passes through under each strut. Image courtesy of St. Jude Medical.

Blog | Stents Bioresorbable | August 16, 2016
There was an explosion of interest in bioresorbable stents immediately following the July 5, 2016 announcement that the...
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell
  August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional Cardiology (...
Gore, Tigris stent, fluoropolymer nitinol stent, peripheral artery disease

The Gore Tigris is a dual-component stent with a unique fluoropolymer / nitinol design.

Technology | Stents Peripheral | August 02, 2016
August 2, 2016 —The U.S. Food and Drug Administration (FDA) granted market clearance for W. L. Gore & Associates’...
Abbott, Absorb bioresorbable stent, dissolving, UAB, University of Alabama at Birmingham, first in state
News | Stents Bioresorbable | July 26, 2016
July 26, 2016 — On July 20, Massoud Leesar, M.D., of University of Alabama at Birmingham Hospital implanted a patient...
bioresorbable stent, bioabsorbable stent, Absorb BVS, visualizing bioresorbable stents

A comparison of how the Abbott Absorb BVS appears with intravascular ultrasound (IVUS) on the left, and optical coherence tomography (OCT) of the right. The stent is difficult to visualize and sizing is critical, so both modalities can help in bioresorbable stent measurements and to confirm stent apposition. Left image from the Volcano IVUS system and the right image from St. Jude Medical's OCT system.

Feature | Stents Bioresorbable | July 21, 2016 | Alphonse Ambrosia, D.O.
Some have labeled bioresorbable scaffolds (BRS), also known as bioresorbable stents, as the fourth evolution of...
Abbott Absorb bioresorbable stent, dissolving BVS, first West Coast implant, Good Samaritan Hospital Los Angeles
News | Stents Bioresorbable | July 19, 2016
July 19, 2016 — Good Samaritan Hospital, Los Angeles, is the first hospital on the West Coast to offer patients with...
Abbott, Absorb bioresorbable stent, University Hospitals Case Medical Center, first Midwest implant
News | Stents Bioresorbable | July 11, 2016
July 11, 2016 — University Hospitals Case Medical Center, Cleveland, is among the first in the country – and the first...
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, dissolving stent

The Abbott Absorb is the first bioresorbable stent to be cleared for use in the United States. 

Technology | Stents Bioresorbable | July 05, 2016 | Dave Fornell
July 5, 2016 — The U.S. Food and Drug Administration (FDA) has cleared the first fully bioresorbable coronary stent for...
Intact Vascular, TOBA III clinical study, Europe, Tack Endovascular System, peripheral artery disease, PAD
News | Peripheral Artery Disease (PAD) | June 07, 2016
June 7, 2016 — Intact Vascular Inc. announced that its Tack Optimized Balloon Angioplasty III (TOBA III) clinical trial...
News | Stents Bioresorbable | June 06, 2016
June 6, 2016 — Amaranth Medical announced that it completed enrollment in May in the RENASCENT-II study of its novel...
Biotronik, ORIENT trial results, EuroPCR 2016, Orsiro DES, hybrid drug-eluting stent
News | Stents Drug Eluting | June 03, 2016
June 3, 2016 — Biotronik announced results establishing non-inferiority of the Orsiro hybrid drug-eluting stent (DES)...
congenital heart, pulmonary artery stenting, JACC study
News | Congenital Heart | May 31, 2016
May 31, 2016 — In a recent study, the use of a stent to repair pulmonary artery stenosis in children and adults with...
Biotronik, Magmaris bioresorbable magnesium scaffold, BIOSOLVE-II Trial, 12-month results, EuroPCR 2016
News | Stents Bioresorbable | May 17, 2016
May 17, 2016 — Biotronik presented 12-month data from the BIOSOLVE-II trial during a Hotline Session at EuroPCR 2016....

Biosensors' Biomatrix stent.

Feature | Stents | May 16, 2016
May 16, 2016 — Cardinal Health announced it has entered into a distribution agreement with Biosensors that enables...